NEWEarnings
AbbVie (ABBV) Trims 2026 Profit Forecast Following Apogee Acquisition
Published on 7/31/2026
AI Summary
Summarized by AI from the source belowAbbVie (ABBV) adjusted its 2026 profit forecast downwards due to the acquisition of Apogee Therapeutics. The company reported second-quarter earnings that exceeded analyst expectations. The updated guidance reflects the financial implications of the acquisition, affecting projected profitability. This revision is significant for investors as it impacts future earnings expectations and may influence AbbVie's stock performance.
Get the free market brief
Top stories and analysis, summarized. No spam, unsubscribe anytime.
